These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26193257)

  • 21. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.
    Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG
    Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
    Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
    Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coptis chinensis and dried ginger herb combination inhibits gastric tumor growth by interfering with glucose metabolism via LDHA and SLC2A1.
    Fu M; Liu Y; Cheng H; Xu K; Wang G
    J Ethnopharmacol; 2022 Feb; 284():114771. PubMed ID: 34737010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer.
    Wei LM; Cao S; Yu WD; Liu YL; Wang JT
    Oncol Rep; 2015 Feb; 33(2):615-24. PubMed ID: 25482732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
    Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A
    Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.
    Tsai CY; Wang CS; Tsai MM; Chi HC; Cheng WL; Tseng YH; Chen CY; Lin CD; Wu JI; Wang LH; Lin KH
    Clin Cancer Res; 2014 May; 20(9):2276-88. PubMed ID: 24602839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway.
    Deng J; Lei W; Xiang X; Zhang L; Lei J; Gong Y; Song M; Wang Y; Fang Z; Yu F; Feng M; Sun Z; Chen J; Zhan Z; Xiong J
    Oncotarget; 2016 Mar; 7(9):10037-50. PubMed ID: 26840256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
    Gong Y; Ren J; Liu K; Tang LM
    World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
    J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis.
    Zhang L; Xia L; Zhao L; Chen Z; Shang X; Xin J; Liu M; Guo X; Wu K; Pan Y; Fan D
    Carcinogenesis; 2015 Mar; 36(3):390-9. PubMed ID: 25653235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation.
    Lu YX; Wu QN; Chen DL; Chen LZ; Wang ZX; Ren C; Mo HY; Chen Y; Sheng H; Wang YN; Wang Y; Lu JH; Wang DS; Zeng ZL; Wang F; Wang FH; Li YH; Ju HQ; Xu RH
    Theranostics; 2018; 8(5):1312-1326. PubMed ID: 29507622
    [No Abstract]   [Full Text] [Related]  

  • 33. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.
    Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y
    Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of ROCK2 in gastric cancer cell promotes tumor cell proliferation, metastasis and invasion.
    Li M; Ke J; Wang Q; Qian H; Yang L; Zhang X; Xiao J; Ding H; Shan X; Liu Q; Xiao Y; Bao B; Huang H
    Clin Exp Med; 2017 Nov; 17(4):519-529. PubMed ID: 27921230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
    Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
    Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Wang H; Zhou R; Sun L; Xia J; Yang X; Pan C; Huang N; Shi M; Bin J; Liao Y; Liao W
    Endocr Relat Cancer; 2017 Nov; 24(11):565-578. PubMed ID: 28874393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.